Disseminated intravascular coagulation

Disseminated intravascular coagulation (DIC) is a condition in which blood clots form throughout the body, blocking small blood vessels. Symptoms may include chest pain, shortness of breath, leg pain, problems speaking, or problems moving parts of the body. As clotting factors and platelets are used up, bleeding may occur. This may include blood in the urine, blood in the stool, or bleeding into the skin. Complications may include organ failure. Relatively common causes include sepsis, surgery, major trauma, cancer, and complications of pregnancy. Less common causes include snake bites, frostbite, and burns. There are two main types: acute (rapid onset) and chronic (slow onset). Diagnosis is typically based on blood tests. Findings may include low platelets, low fibrinogen, high INR, or high D-dimer. Treatment is mainly directed towards the underlying condition. Other measures may include giving platelets, cryoprecipitate, or fresh frozen plasma. Evidence to support these treatments, however, is poor. Heparin may be useful in the slowly developing form. About 1% of people admitted to hospital are affected by the condition. In those with sepsis, rates are between 20% and 50%. The risk of death among those affected varies from 20% to 50%. In DIC, the underlying cause usually leads to symptoms and signs, and DIC is discovered on laboratory testing. The onset of DIC can be sudden, as in endotoxic shock or amniotic fluid embolism, or it may be insidious and chronic, as in cancer. DIC can lead to multiorgan failure and widespread bleeding. DIC can occur in the following conditions: Cancer: solid tumors and blood cancers (particularly acute promyelocytic leukemia) Complications of pregnancy: abruptio placentae, pre-eclampsia or eclampsia, amniotic fluid embolism, retained intrauterine fetal demise, septic abortion, postpartum hemorrhage Massive tissue injury: trauma, burn, hyperthermia, rhabdomyolysis, surgery Infection: bacterial (Gram-negative or Gram-positive), viral, fungal, or protozoan Transfusion reaction: ABO incompatibility Allergic or toxic reaction: snake venom Hemangioma: Kasabach–Merritt syndrome Aortic aneurysm Liver disease, HELLP syndrome, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and malignant hypertension may mimic DIC but originate via other pathways.

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related concepts (55)

Related courses (1)

Related lectures (14)

Disseminated intravascular coagulation

Hemolytic–uremic syndrome

Hemolytic–uremic syndrome (HUS) is a group of blood disorders characterized by low red blood cells, acute kidney failure, and low platelets. Initial symptoms typically include bloody diarrhea, fever, vomiting, and weakness. Kidney problems and low platelets then occur as the diarrhea progresses. Children are more commonly affected, but most children recover without permanent damage to their health, although some children may have serious and sometimes life-threatening complications.

Lipopolysaccharide

Lipopolysaccharides (LPS) are large molecules consisting of a lipid and a polysaccharide that are bacterial toxins. They are composed of an O-antigen, an outer core, and an inner core all joined by covalent bonds, and are found in the outer membrane of Gram-negative bacteria. Today, the term endotoxin is often used synonymously with LPS, although there are a few endotoxins (in the original sense of toxins that are inside the bacterial cell that are released when the cell disintegrates) that are not related to LPS, such as the so-called delta endotoxin proteins produced by Bacillus thuringiensis.

CH-317: Drug discovery and development

This course discusses the molecular basis of diseases and how drugs work. Concepts and processes employed in today's drug discovery and development are covered. The first part of the course focuses on

Ceramics: Synthesis and Precipitation MSE-214: Mise en oeuvre des matériaux I

Explores ceramics, focusing on synthesis by precipitation and related concepts like surface energy and spray pyrolysis.

Protein Therapeutics: Blood Proteins and Enzymes CH-317: Drug discovery and development

Explores blood composition, proteins, coagulation, diseases treated with enzymes, and case studies on genetic disorders.

Plasma Medicine: Applications Overview MOOC: Plasma Physics: Introduction

Explores the applications of plasma medicine in wound healing, dentistry, and cancerology.